Inventiva (IVA) Receivables Refunds (2018 - 2025)
Inventiva (IVA) recorded quarterly Receivables Refunds of $2.7 million in Q4 2025, up 308.5% quarter-over-quarter from -$1.3 million in Q2 2025, and down 49.29% on a YoY basis from $5.2 million in Q4 2024.
Inventiva (IVA) Receivables Refunds (2018 - 2025) Analysis & Trends
Inventiva's Receivables Refunds history runs 8 years deep, the most recent figure standing at $2.7 million for Q4 2025.
- In Q4 2025, Receivables Refunds fell 49.29% year-over-year to $2.7 million; the TTM figure through Dec 2025 stood at $2.7 million (down 49.29% YoY), while the FY2025 annual figure was $2.7 million, down 49.29% from the prior year.
- Receivables Refunds was $2.7 million for Q4 2025 at Inventiva, up from -$1.3 million in the prior quarter.
- In the past five years, Receivables Refunds ranged from a high of $6.1 million in Q4 2022 to a low of -$4.0 million in Q2 2023.
- Historically, Receivables Refunds has averaged $1.3 million across 5 years, with a median of -$20622.0 in 2021.
- The sharpest annual moves came in 2022 and 2023: Receivables Refunds soared 104.74% in 2022, then plunged 19666.62% in 2023.
- A 5-year view of Receivables Refunds shows it stood at $5.0 million in 2021, then climbed by 22.51% to $6.1 million in 2022, then dropped by 6.04% to $5.8 million in 2023, then declined by 9.07% to $5.2 million in 2024, then slumped by 49.29% to $2.7 million in 2025.
- The last three Receivables Refunds figures came in at $2.7 million (Q4 2025), -$1.3 million (Q2 2025), and $5.2 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Refund Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Inventiva | 8.78 Mn | -259.95 Mn | - | 2.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.66 Mn |
| Jun 30, 2025 | -1.27 Mn |
| Dec 31, 2024 | 5.24 Mn |
| Jun 30, 2024 | -128,149.62 |
| Dec 31, 2023 | 5.76 Mn |
| Jun 30, 2023 | -3.97 Mn |
| Dec 31, 2022 | 6.13 Mn |
| Sep 22, 2022 | -2.75 Mn |
| Jun 30, 2022 | 20,274.08 |
| Dec 31, 2021 | 5.00 Mn |
| Jun 30, 2021 | -427,516.36 |
| Mar 31, 2021 | -61,518.04 |
| Dec 31, 2020 | 10.76 Mn |
| Jun 30, 2020 | 3.27 Mn |
| Mar 31, 2020 | -937,244.23 |
| Dec 31, 2019 | 10.88 Mn |
| Dec 31, 2018 | 10.77 Mn |